Kamal Masaki to Estrogen Replacement Therapy
This is a "connection" page, showing publications Kamal Masaki has written about Estrogen Replacement Therapy.
Connection Strength
0.285
-
Espeland MA, Brinton RD, Manson JE, Yaffe K, Hugenschmidt C, Vaughan L, Craft S, Edwards BJ, Casanova R, Masaki K, Resnick SM. Postmenopausal hormone therapy, type 2 diabetes mellitus, and brain volumes. Neurology. 2015 Sep 29; 85(13):1131-8.
Score: 0.134
-
Shumaker SA, Legault C, Kuller L, Rapp SR, Thal L, Lane DS, Fillit H, Stefanick ML, Hendrix SL, Lewis CE, Masaki K, Coker LH. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study. JAMA. 2004 Jun 23; 291(24):2947-58.
Score: 0.062
-
Hsia J, Criqui MH, Rodabough RJ, Langer RD, Resnick HE, Phillips LS, Allison M, Bonds DE, Masaki K, Caralis P, Kotchen JM. Estrogen plus progestin and the risk of peripheral arterial disease: the Women's Health Initiative. Circulation. 2004 Feb 10; 109(5):620-6.
Score: 0.061
-
Bell CL, LaCroix A, Masaki K, Hade EM, Manini T, Mysiw WJ, Curb JD, Wassertheil-Smoller S. Prestroke factors associated with poststroke mortality and recovery in older women in the Women's Health Initiative. J Am Geriatr Soc. 2013 Aug; 61(8):1324-30.
Score: 0.029